Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2- breast cancer that had progressed during or after prior endocrine therapy
| Image |  |
|---|---|
| Description | scientific article published on 10 February 2017 |
| Author/s |
author: Javier Cortes A Musolino Patrick Neven Fabrice André |
| Publication date | February 10, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |